Odyssean »

Orion Engineered Carbons shares owned by Odyssean

Quarter-by-quarter ownership of Orion Engineered Carbons (OEC) shares owned by Odyssean from 13F filings

Historical chart of Odyssean investment in Orion Engineered Carbons

Tip: Access up to 7 years of quarterly data

All positions including Orion Engineered Carbons held by Odyssean consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Orion Engineered Carbons by Odyssean

Quarter filed Position value Share count Share price at filing
2026-06-30 $234k 35k 6.63

More positions owned by Odyssean

Ultragenyx Pharmaceutical (RARE)
Kymera Therapeutics (KYMR)
Ideaya Biosciences (IDYA)
Vaxcyte (PCVX)
Affirm Hldgs Com Cl A (AFRM)
Celldex Therapeutics Com New (CLDX)
Loar Holdings Com Shs (LOAR)
Mirum Pharmaceuticals (MIRM)
Doordash Cl A (DASH)
Krystal Biotech (KRYS)
Viking Holdings Ord Shs (VIK)
Medpace Hldgs (MEDP)
Toast Cl A (TOST)
American Healthcare Reit Com Shs (AHR)
Nicolet Bankshares (NIC)

View all positions for Odyssean

Top funds holding Orion Engineered Carbons

Pzena Investment Management
BlackRock
Divisar Capital Management
American Century Companies
D. E. Shaw & Co
Dimensional Fund Advisors
AQR Capital Management
Invesco
Charles Schwab Investment Management
Morgan Stanley
Hanna Zanoni
Harvey Partners
Geode Capital Management
State Street Corporation
Vanguard Portfolio Management

View all funds holding Orion Engineered Carbons